US Bancorp
CGON icon

US Bancorp’s CG Oncology CGON Stock Holding History

US Bancorp’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.8K Buy
645
+2
+0.3% +$131 ﹤0.01% 2837
2026
Q1 		$43.5K Buy
643
+36
+6% +$2.04K ﹤0.01% 2776
2025
Q4 		$25.2K Hold
607
– – ﹤0.01% 2992
2025
Q3 		$24.4K Sell
607
-21
-3% -$611 ﹤0.01% 2986
2025
Q2 		$16.3K Buy
628
+415
+195% +$10K ﹤0.01% 3246
2025
Q1 		$5.22K Buy
213
+123
+137% +$3.46K ﹤0.01% 3644
2024
Q4 		$2.58K Sell
90
-14
-13% -$479 ﹤0.01% 3807
2024
Q3 		$3.92K Sell
104
-172
-62% -$6.03K ﹤0.01% 3646
2024
Q2 		$8.71K Buy
+276
New +$9.57K ﹤0.01% 3360

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

US Bancorp's CGON Position: Q2 2026 in Review

US Bancorp increased its CG Oncology (CGON) stake by 0.31% in Q2 2026, buying an estimated $131 and bringing the position to 645 shares worth $45.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2837.

US Bancorp first reported a position in CGON in Q2 2024 and has held it in 9 quarters since. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • US Bancorp held 645 shares of CG Oncology worth $45.8K as of Q2 2026.
  • US Bancorp bought 2 CG Oncology shares in Q2 2026, an estimated $131.
  • CG Oncology made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #2837 holding.
  • US Bancorp first reported a position in CG Oncology in Q2 2024 and has held it in 9 quarters since.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.